 Clinical Oncology News | Adjuvant Radiation After R-CHOP-14 Increases Lymphoma Survival Clinical Oncology News While the addition of rituximab had clearly contributed to increased response rates, event-free survival and OS in PMLBCL, the role of radiotherapy in the rituximab era has been controversial, with some small nonrandomized studies suggesting that the ... |
